Medifast, Inc. provided earnings guidance for the third quarter 2023. For the period, the company expects revenue to be in the range of $220 million to $240 million and third quarter 2023 diluted EPS to be in the range of $0.71 to $1.32.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.32 USD | -0.16% | -1.56% | -62.33% |
04-30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
04-30 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.33% | 271M | |
+17.39% | 8.62B | |
+6.26% | 7.68B | |
+7.55% | 6.38B | |
-7.57% | 3.74B | |
-5.30% | 3.71B | |
-1.78% | 1.34B | |
-27.39% | 1.12B | |
+18.29% | 1.05B | |
-9.48% | 913M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast, Inc. Provides Earnings Guidance for the Third Quarter 2023